KRM Ayurveda Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹17(12.59%)
Premium (ELP)
KRM Ayurveda Limited's achieved publicly listed status following its IPO debut on Jan 29, 2026 at the NSE platform. The offering successfully mobilized 57,40,000 Shares, with 57,40,000 Shares allocated to corporate growth initiatives.
Investment participation occurred within the established price band of ₹128 to ₹135, starting from minimum lots of 1000 shares. The subscription window from Jan 21, 2026 through Jan 23, 2026 enabled investor participation across market segments.
Share allocation was completed on Jan 27, 2026, determining ownership distribution among successful applicants. The listing represents a milestone achievement, transitioning the company to regulated public market status with associated responsibilities and opportunities.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated on 3 September 2019, KRM Ayurveda Ltd operates a network of hospitals and clinics across several cities in India and has also expanded its presence internationally through telemedicine consultations and online sales. The company is engaged in manufacturing Ayurvedic products, including herbal and botanical remedies, medicines, supplements, and wellness or skincare-related items. Currently, it manages six hospitals and five clinics at different locations in the country, offers teleconsultation services, and sells KRM Ayurveda products, with a total workforce of 429 employees across various departments as of August 31, 2025.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Qualified Ayurvedic Professionals: Experienced doctors and certified therapists ensure consistent treatment quality.
- GMP-Certified Manufacturing: Centralized GMP facility ensures safe and effective Ayurvedic medicines.
- Trusted Brand & Repeat Clients: Strong patient trust leads to recurring business and brand strength.
- Non-Ownership of Premises: Operations run from leased hospitals and offices, and relocation could disrupt services.
- Employee Attrition Risk: High attrition among frontline and technical staff may affect service quality and growth.
- Geographical Revenue Concentration: Dependence on two key states increases exposure to regional risks.
- Mr. Puneet Dhawan
- Mrs. Tanya Dhawan
KRM Ayurveda Limited
Skyline Financial Services Private Limited